1:2:1 Podcast

Irving Weissman on proposed NIH stem cell guidelines

Irving Weissman, MD, the director of stem cell research at the School of Medicine says he is troubled by draft guidelines recently issued by the National Institutes of Health that would prohibit federal funding for research on stem cell lines created through a technique sometimes referred to as "therapeutic cloning" or somatic cell nuclear transfer. He discusses his concerns with Paul Costello in this podcast.

Length: 19 mins. 42 sec.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.